BWP
PACB icon

BSW Wealth Partners’s Pacific Biosciences PACB Stock Holding History

BSW Wealth Partners’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,415
Closed -$152K – 275
2023
Q2 		$152K Sell
11,415
-159
-1% -$1.93K 0.03% 265
2023
Q1 		$134K Sell
11,574
-667
-5% -$6.63K 0.03% 303
2022
Q4 		$100K Buy
12,241
+393
+3% +$3.39K 0.02% 298
2022
Q3 		$69K Buy
11,848
+702
+6% +$4.03K 0.02% 264
2022
Q2 		$49K Buy
+11,146
New +$67.7K 0.01% 275

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BSW Wealth Partners's PACB Position: Q3 2023 in Review

BSW Wealth Partners sold out of Pacific Biosciences (PACB) in Q3 2023, closing a stake of 11,415 shares — an estimated $152K sold.

BSW Wealth Partners first reported a position in PACB in Q2 2022 and held it in 5 quarters. The position peaked at $152K in Q2 2023. 274 funds tracked by Wall St. Rank hold PACB as of Q3 2023.

  • BSW Wealth Partners reported no remaining Pacific Biosciences position as of Q3 2023 after selling out during the quarter.
  • BSW Wealth Partners sold 11,415 Pacific Biosciences shares in Q3 2023, an estimated $152K.
  • BSW Wealth Partners first reported a position in Pacific Biosciences in Q2 2022 and held it in 5 quarters.
  • BSW Wealth Partners's Pacific Biosciences position peaked at $152K in Q2 2023.
  • 274 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2023.

Based on BSW Wealth Partners's 13F filing for Q3 2023, filed 27 Oct 2023.